Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel mechanism of antitumor activity demonstrated for NK-314

April 19, 2005

Selective dual-specificity phosphatase inhibitors with potential as anticancer agents

April 19, 2005

Bionaut and AnalytiCon Discovery sign lead optimization agreement for cancer

April 19, 2005

U.K. clearance for phase IIb CoFactor study in metastatic colorectal cancer

April 19, 2005

2ME2 receives orphan drug designation for ovarian cancer

April 19, 2005

Genentech extends support of Curis collaborative efforts

April 19, 2005

Leinamycin prodrug activated by oxidative stress in prostate tumor cells

April 19, 2005

ZSTK-474: a novel PI3K inhibitor with a promising preclinical profile

April 18, 2005

SDF-1 antagonist significantly reduces osteosarcoma metastases in animal model

April 18, 2005

Cloretazine studied in phase I trial for pediatric brain tumors

April 18, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...